Advertisement
Advertisement
GPCR
Structure Therapeutics Inc. - ADR
47.42
USDSponsored
+1.81
+3.97%
Jun 24, 11:31 UTC -4
Open
GPCR Earnings Reports
Positive Surprise Ratio
GPCR beat 2 of 14 last estimates.
14%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.40
Implied change from Q1 26 (Revenue/ EPS)
--
/+14.29%
Implied change from Q2 25 (Revenue/ EPS)
--
/-62.96%
Structure Therapeutics Inc. - ADR earnings per share and revenue
On May 07, 2026, GPCR reported earnings of -0.35 USD per share (EPS) for Q1 26, beating the estimate of -0.35 USD, resulting in a 1.21% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.14% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an increase of 14.29% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Structure Therapeutics Inc. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Structure Therapeutics Inc. - ADR reported EPS of -$0.35, beating estimates by 1.21%, and revenue of $0.00, 0% as expectations.
How did the market react to Structure Therapeutics Inc. - ADR's Q1 2026 earnings?
The stock price moved down -4.14%, changed from $40.84 before the earnings release to $39.15 the day after.
When is Structure Therapeutics Inc. - ADR expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Structure Therapeutics Inc. - ADR's next earnings report?
Based on 12
analysts, Structure Therapeutics Inc. - ADR is expected to report EPS of -$0.40 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement